Analyst Downgrades: Amgen, Inc., Teva Pharmaceutical Industries Ltd, and HP Inc

Analysts downwardly revised their ratings and price targets on Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (TEVA), and HP Inc (HPQ)

Aug 25, 2016 at 10:05 AM
facebook X logo linkedin

Analysts are weighing in on drugmakers Amgen, Inc. (NASDAQ:AMGN) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), as well as tech stock HP Inc (NYSE:HPQ). Here's a quick roundup of today's bearish brokerage notes on AMGN, TEVA, and HPQ.

  • Morgan Stanley trimmed its price target on AMGN to $198 from $199, after the U.S. Food and Drug Administration (FDA) rejected the drugmaker's request to market Parsabiv for secondary hyperparathyroidism. These developments have dropped the stock 0.5% to $169.96. However, Amgen, Inc. remains fairly close to its annual high of $176.64, touched one week ago. If options traders have their druthers, the stock will continue to drift lower. During the last 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), speculators have bought to open 1.80 puts for every call -- a ratio ranking just 4 percentage points from an annual peak.
  • TEVA was dealt a legal blow yesterday, when the U.S. Patent and Trademark Office invalidated a pair of patents for multiple sclerosis drug Copaxone. The negative momentum is spilling over into today, with the stock down 0.6% at $51.30 -- with losses exacerbated by Morgan Stanley's $6 price-target cut to $63. This isn't particularly out of the ordinary for Teva Pharmaceutical Industries Ltd shares, though, as they've surrendered roughly 22% year-to-date. Losses could mount if upbeat brokerage firms begin to rethink their assessments. At present, 11 analysts rate TEVA a "buy" or better, compared to five "holds" and zero "sells" -- leaving the door wide open for potential downgrades.
  • HPQ has dropped 4.6% to trade at $13.74, pressured by the company's weak earnings forecast -- which is overshadowing better-than-expected fiscal third-quarter results. Adding fuel to the bearish fire, Maxim downgraded its rating to "hold" from "buy," and cut its target price to $15 from $17. On the other hand, at least five analysts raised their price targets on HP Inc. Technically speaking, the shares have been red-hot since their early February lows just south of $9, and are currently trying to establish a foothold at their rising 50-day moving average. Options players certainly wouldn't mind a bounce. HPQ's 10-day ISE/CBOE/PHLX call/put volume ratio of 3.83 sits 2 percentage points from a 12-month peak.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI